Nasdaq Markets

In recent trading, shares of Yext Inc (Symbol: YEXT) have crossed above the average analyst 12-month target price of $18.83, changing hands for $19.86/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse

(RTTNews) - German stocks rose on Tuesday after a survey showed Euro zone manufacturing activity remained on a recovery path last month, with conditions improving for the second straight month.

(RTTNews) - A.P. Moller - Maersk (AMKAF.PK, AMKBF.PK) said, from 1 January 2021, the Safmarine brand will be fully transitioned into the Maersk brand. The Safmarine brand will no longer be marketed by the end of 2020. As of October 2020, Safmarine teams will begin to integrate i

Image source: The Motley Fool.

(RTTNews) - Asian stocks ended mixed on Tuesday as concerns about rising coronavirus cases and geopolitical tensions offset data showing that China's manufacturing sector continued to expand in August.

(RTTNews) - Air China Ltd (AIRC.L) reported Tuesday that its first-half loss before taxation was RMB 13.10 billion, compared to last year's profit of RMB 4.51 billion.

(RTTNews) - Seabourn announced that it will cancel additional voyages for three cruise ships in its fleet. This applies to Seabourn Ovation, Seabourn Encore, and Seabourn Quest. For Seabourn Ovation, operations pause will be effective through January 3, 2021. For Seabourn Encore

(RTTNews) - Oxford Biomedica plc (OXB.L), a gene and cell therapy group, announced Tuesday that it has signed a supply agreement with AstraZeneca Plc (AZN.L, AZN) to expand manufacturing support of COVID-19 vaccine candidate, AZD1222.

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) said detailed results from the phase III DAPA-CKD trial showed that the company's Farxiga (dapagliflozin) on top of standard of care reduced the composite measure of worsening of renal function or risk of cardiovascular or renal death by

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced Tuesday that the European Union has approved Imfinzi (durvalumab) for the 1st-line treatment of extensive-stage small cell lung cancer or ES-SCLC.

(RTTNews) - Novartis said it has committed to increase patient reach with its strategic medicines by at least 200% by 2025, as part of its ambition to expand access to medicines in low- and middle-income countries or LMICs.

(RTTNews) - European stocks may open a tad higher on Tuesday after a private survey showed China's factory activity expanded at the fastest clip in nearly a decade in August.

(RTTNews) - Roche (RHHBY) announced FDA has approved the cobas HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas 6800/8800 Systems in the U.S. The test provides a single result to confirm HIV diagnosis and differentiate HIV-1 and HIV-2.

(RTTNews) - Sanofi (SNYNF, SNY) announced Tuesday that the Phase 3 trial of Kevzara (sarilumab) did not meet its primary endpoint and key secondary endpoint in COVID-19 patients outside the U.S.

(RTTNews) - Indian shares opened on a positive note Tuesday after a sharp sell-off in the previous session. Weak GDP data as well as heightened geopolitical tensions between India and China served to keep underlying sentiment cautious to some extent.

(RTTNews) - Today's Daily Dose brings you news about Acasti Pharma's phase III trial of CaPre, Merger Monday, CorMedix's regulatory catalyst, Vanda Pharma's anticipated milestones, and the progress in Vir/Glaxo's COVID-19 trial.

(RTTNews) - Asian stock markets are mostly higher on Tuesday despite the mixed cues overnight from Wall Street. Data showing that China's manufacturing sector continued to expand in August and signaled a recovery from the coronavirus pandemic helped boost investor sentiment.

(RTTNews) - Zoom Video Communications Inc. (ZM) reported that its second-quarter net income attributable to common stockholders surged to $185.7 million or $0.63 per share from $5.5 million or $0.02 per share in the second quarter of fiscal year 2020.